Molar Incisor Hypomineralization (MIH) is a disease causing a structural defect in the enamel of permanent teeth. The treatment of these teeth consists of the removal of the affected part of the tooth and its reconstitution. Classically, the restoration is done with a resin in direct method. With the development of Computer-aided design (CAD) and Computer-aided manufacturing (CAM), it is possible to make a custom-made part to replace the affected part of the tooth. The main objective is to describe the effect of the 6-month management of CAD/CAM type restorations compared to direct restorations, performed in children aged 7 to 12 years with mild to moderate MIH on permanent molar teeth.
Full Title of Study: “Computer-aided Design/Computer-aided Manufacturing for Mild to Moderate Molar Incisor Hypomineralization Treatment : a Pilot Study”
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: June 2023
Molar Incisor Hypomineralization (MIH) is a structural defect of the enamel affecting at least one of the first four permanent molars. The prevalence is high, ranging from 20% to 40% of children. The consequences of MIH are multiple, including pain during food intake or an increased risk for the development of carious disease. The current standard protocol for mild to moderate MIH is the use of direct restorations (Glass Cement Ionomer type). However, this therapy is not suitable due to frequent failures. In terms of longevity, indirect restorations are superior to direct restorations. CAD/CAM in dentistry offers the possibility of making these inlay/onlay type perennial coronary restorations. It is faster to implement and does not require a conventional impression.
- Procedure: Indirect ceramic restoration
- Indirect ceramic restoration using an optical impression.
- Procedure: Direct restoration
- Restoration using a Glass Ionomer Cement
Arms, Groups and Cohorts
- Experimental: CAD/CAM Group
- For the CAD/CAM group, an indirect ceramic restoration will be made using an optical impression.
- Active Comparator: Direct method Group
- For the direct method group, a restoration using a Glass Ionomer Cement will be performed.
Clinical Trial Outcome Measures
- Treatment effect
- Time Frame: 6 months
- The effect of the management of the MIH will be assessed by the occurrence of failure. Failure will be diagnosed from the degree of demineralisation measured, by laser fluorescence at the peripheral tooth/restoration joint. The values collected range from 0 to 99 and are categorised into 3 situations : From 0 to 12: situation without demineralization, tight seal. From 13 to 24: start of demineralization ≥ 25: therapeutic failure, non-watertight seal, restoration to be redone without delay.
- Time Frame: 3 months
- Failure diagnosed according to the degree of demineralisation measured, every 3 months following the restoration, by laser fluorescence at the peripheral tooth/restoration joint.
- Time Frame: 12 months
- Failure diagnosed according to the degree of demineralisation measured, every 12 months following the restoration, by laser fluorescence at the peripheral tooth/restoration joint.
Participating in This Clinical Trial
1. Child from 7 to 12 years old presenting a mild to moderate HIN on at least one permanent first molar requiring reconstitution. 2. Child presenting a state of anxiety compatible with the provision of oral care (score on the Venham scale modified by Veerkamp below 2). 3. Child affiliated to or benefiting from a social security scheme. 4. Free, informed and signed consent by the parent(s)/holder(s) of parental authority and the investigator (at the latest on the day of inclusion and before any examination required by the research). 5. Oral consent of the child.
- Noninclusion criteria:
1. Child presenting an allergy or a history of allergy to one of the constituents of biomaterials 2. Child with fluorosis 3. Child with amelogenesis imperfecta 4. Child with pacemaker (contraindication to CAD/CAM) -
Gender Eligibility: All
Minimum Age: 7 Years
Maximum Age: 12 Years
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- University Hospital, Toulouse
- Provider of Information About this Clinical Study
- Overall Official(s)
- Mathieu MARTY, Principal Investigator, University Hospital of Toulouse
- Overall Contact(s)
- Mathieu MARTY, 06.79.97.47.11, email@example.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.